Presentation Information
[29P-pm111]Development of the bicyclic mid-size peptide KS-133 as a VIPR2-specific antagonist and its antitumor effect through modulation of macrophage polarity
○Kotaro Sakamoto1, Eijiro Miyako2, Shinsaku Nakagawa3, Yukio Ago4, Akira Nishiyama5 (1. Ichimaru Pharcos co. Ltd., 2. JAIST, 3. Osaka Univ., 4. Hiroshima Univ., 5. Kagawa Univ.)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.